Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta

The Boost Brittle Bones Before Birth (BOOSTB4) clinical trial is investigating the safety and efficacy of transplanting fetal derived mesenchymal stromal cells (MSCs) prenatally and/or in early postnatal life to treat severe Osteogenesis Imperfecta (OI). This study aimed to explore stakeholder views...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hum Genet
Main Authors: Hill, Melissa, Lewis, Celine, Riddington, Megan, Crowe, Belinda, DeVile, Catherine, David, Anna L., Semler, Oliver, Westgren, Magnus, Götherström, Cecilia, Chitty, Lyn S
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6777523/
https://ncbi.nlm.nih.gov/pubmed/30918362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41431-019-0387-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares